A history of cancer chemotherapy - PubMed (original) (raw)
A history of cancer chemotherapy
Vincent T DeVita Jr et al. Cancer Res. 2008.
Abstract
The use of chemotherapy to treat cancer began at the start of the 20th century with attempts to narrow the universe of chemicals that might affect the disease by developing methods to screen chemicals using transplantable tumors in rodents. It was, however, four World War II-related programs, and the effects of drugs that evolved from them, that provided the impetus to establish in 1955 the national drug development effort known as the Cancer Chemotherapy National Service Center. The ability of combination chemotherapy to cure acute childhood leukemia and advanced Hodgkin's disease in the 1960s and early 1970s overcame the prevailing pessimism about the ability of drugs to cure advanced cancers, facilitated the study of adjuvant chemotherapy, and helped foster the national cancer program. Today, chemotherapy has changed as important molecular abnormalities are being used to screen for potential new drugs as well as for targeted treatments.
Similar articles
- Battling the hematological malignancies: the 200 years' war.
Lichtman MA. Lichtman MA. Oncologist. 2008 Feb;13(2):126-38. doi: 10.1634/theoncologist.2007-0228. Oncologist. 2008. PMID: 18305057 - The historical development of cancer chemotherapy.
Burchenal JH. Burchenal JH. Semin Oncol. 1977 Jun;4(2):135-46. Semin Oncol. 1977. PMID: 327552 Review. No abstract available. - The present state of development of cancer chemotherapy.
Ziegler JL. Ziegler JL. Fed Proc. 1979 Jan;38(1):97-102. Fed Proc. 1979. PMID: 365587 - Cancer chemotherapy in historical perspective.
Kardinal CG. Kardinal CG. J La State Med Soc. 1993 Apr;145(4):175-7. J La State Med Soc. 1993. PMID: 8486991 - Regional chemotherapy: overview.
Muchmore JH, Wanebo HJ. Muchmore JH, et al. Surg Oncol Clin N Am. 2008 Oct;17(4):709-30, vii. doi: 10.1016/j.soc.2008.04.013. Surg Oncol Clin N Am. 2008. PMID: 18722914 Review.
Cited by
- Cardiotoxicity associated with targeted cancer therapies.
Chen ZI, Ai DI. Chen ZI, et al. Mol Clin Oncol. 2016 May;4(5):675-681. doi: 10.3892/mco.2016.800. Epub 2016 Mar 3. Mol Clin Oncol. 2016. PMID: 27123262 Free PMC article. - Mustard vesicants alter expression of the endocannabinoid system in mouse skin.
Wohlman IM, Composto GM, Heck DE, Heindel ND, Lacey CJ, Guillon CD, Casillas RP, Croutch CR, Gerecke DR, Laskin DL, Joseph LB, Laskin JD. Wohlman IM, et al. Toxicol Appl Pharmacol. 2016 Jul 15;303:30-44. doi: 10.1016/j.taap.2016.04.014. Epub 2016 Apr 26. Toxicol Appl Pharmacol. 2016. PMID: 27125198 Free PMC article. - Research advances on how metformin improves memory impairment in "chemobrain".
Alhowail A, Chigurupati S. Alhowail A, et al. Neural Regen Res. 2022 Jan;17(1):15-19. doi: 10.4103/1673-5374.314284. Neural Regen Res. 2022. PMID: 34100420 Free PMC article. - The Sirt1/Nrf2 pathway is a key factor for drug therapy in chemotherapy-induced cardiotoxicity: a Mini-Review.
Mohammad SIS, Vasudevan A, Enwa FO, Bansal J, Chahar M, Eldesoqui M, Ullah MI, Gardanova ZR, Hulail HM, Zwamel AH. Mohammad SIS, et al. Med Oncol. 2024 Sep 11;41(10):244. doi: 10.1007/s12032-024-02494-3. Med Oncol. 2024. PMID: 39259412 Review. - Systemic Immunometabolism: Challenges and Opportunities.
Lercher A, Baazim H, Bergthaler A. Lercher A, et al. Immunity. 2020 Sep 15;53(3):496-509. doi: 10.1016/j.immuni.2020.08.012. Immunity. 2020. PMID: 32937151 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources